Novel antifungal drugs against fungal pathogens: do they provide promising results for treatment? - Wikidata - wikimedia - TriplyDB

Novel antifungal drugs against fungal pathogens: do they provide promising results for treatment?

Novel antifungal drugs against fungal pathogens: do they provide promising results for treatment?

http://www.wikidata.org/entity/Q35220799

about

The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis.

P2860

Q36264982-6E848CD6-74D7-4B30-AB4C-042DD6F9B927

P2860

Novel antifungal drugs against fungal pathogens: do they provide promising results for treatment?

http://www.wikidata.org/entity/Q35220799

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Novel antifungal drugs against ...... omising results for treatment?

@ast

Novel antifungal drugs against ...... omising results for treatment?

@en

type

label

Novel antifungal drugs against ...... omising results for treatment?

@ast

Novel antifungal drugs against ...... omising results for treatment?

@en

prefLabel

Novel antifungal drugs against ...... omising results for treatment?

@ast

Novel antifungal drugs against ...... omising results for treatment?

@en

P1433

Q35220799-BFC38C3E-4A4B-4197-B171-4C1E8A5682DB

P1476

Q35220799-C88D0891-93C4-4815-9892-C38E2C387225

P2093

Q35220799-0CD1C55A-B332-4A4A-8A62-5FC052A1828F

Q35220799-131B2F53-8D46-4E8B-A77F-366058C01F07

Q35220799-4CDEA25D-C428-4B1C-949E-ED71C081510E

Q35220799-7E5F4E3A-E180-4E99-A072-8728377E5101

Q35220799-901918BE-79D5-488E-8A83-185A54C7FE2F

Q35220799-B7F027CF-3BBA-4C8D-B948-873A8469E9AD

Q35220799-BBF8E7C4-4A59-4BFA-9B0F-5F6C5B18C3AD

Q35220799-C8EE376D-F055-4C8A-BCFE-70951DA1111A

P2860

Q35220799-02E452F0-383B-47F4-9827-D8086182E042

Q35220799-04585B34-4607-4F68-83FE-1474E7C98A99

Q35220799-09F19D75-772D-4061-A43F-6C4B8CBD5E7E

Q35220799-126D0493-CB38-490E-8240-244B27A0776F

Q35220799-1E8A0BE9-9C3F-4033-9995-BBFE50603242

Q35220799-28168A84-656A-4DD2-8229-8E12734DF95F

Q35220799-334140E5-FFBA-4582-ACCC-BACF8579A296

Q35220799-35C4D5E4-3260-46D0-BF9C-E0929277EE68

Q35220799-35C5EB73-6ABF-454F-AA63-8526EDC99094

Q35220799-38A376A3-547C-433D-BFF4-122E293F09E6

P2888

Q35220799-347DBEB2-8036-4285-B7A1-9D54B271CF27

P304

Q35220799-28BE36FE-CF8D-4C61-9A52-3FDD17B99F19

P31

Q35220799-C15E2471-A124-4D72-A851-0AEAD3116A7E

P356

Q35220799-14C4E5FC-A33D-44E9-966D-42325B351A36

P433

Q35220799-87D95D42-6BDB-4576-85EA-52E4F13A5BEA

P478

Q35220799-C0E066D3-FC34-4C64-BF0D-054AA150B145

P577

Q35220799-B590A3F2-400B-4425-841C-7F73B452AF76

P698

Q35220799-7806C002-1E7E-40FB-8BAB-CFB98BDFAEDD

P932

Q35220799-D383452B-6BC8-4D1B-A6C3-DBDFD7F4F1D5

P356

S12288-014-0370-8

P1433

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

P1476

Novel antifungal drugs against ...... omising results for treatment?

@en

P2093

Arzu Kantürk

http://www.w3.org/2001/XMLSchema#string

Demet Aydın

http://www.w3.org/2001/XMLSchema#string

Deniz Arıca

http://www.w3.org/2001/XMLSchema#string

Funda Şimşek

http://www.w3.org/2001/XMLSchema#string

Habip Gedik

http://www.w3.org/2001/XMLSchema#string

Naciye Demirel

http://www.w3.org/2001/XMLSchema#string

Osman Yokuş

http://www.w3.org/2001/XMLSchema#string

Taner Yıldırmak

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

Correlates of acute renal failure in patients receiving parenteral amphotericin B.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Management of febrile neutropenia: ESMO Clinical Practice Guidelines.

P2888

s12288-014-0370-8

P304

196-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12288-014-0370-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25825558

http://www.w3.org/2001/XMLSchema#string

P932

4375158

http://www.w3.org/2001/XMLSchema#string